HOME >> MEDICINE >> NEWS
Prebiotics can cut development of skin allergy in babies at high risk

Prebiotics can cut the chances of developing atopic dermatitis in babies at high risk of the disorder, suggests a study published ahead of print in the Archives of Disease in Childhood .

Human breast milk contains natural prebiotics (oligosaccharides), which promote the growth of bacteria, such as lactobacilli and bifidobacteria that boost the development of a healthy immune system.This can help prevent allergies in a very young child.

Researchers developed an infant formula based on the prebiotic content of human breast milk and tested it out on a group of babies one of other of whose parents had atopic eczema, or allergic rhinitis, or asthma.

All the mothers were advised to breastfeed their babies, all of whom were born after a normal length pregancy. But for those unable to start or continue, their babies were divided into two groups, with 102 given a prebiotic formula feed and 104 given a normal formula.

The babies were seen on a monthly basis up to the age of 6 months, and their parents kept a symptom diary.

Over the six months, only 10 babies fed the prebiotic formula developed atopic dermatitis, compared with 24 fed the normal formula. An assessment of stool samples from 98 of the babies showed a significant increase in bifidobacteria in those fed the prebiotic feed.

This strongly suggests that formula feed supplemented with prebiotics can modify the bowel bacteria and so reduce the chance of developing atopic dermatitis among children at high risk of the disorder


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
440-207-383-6529
BMJ Specialty Journals
26-Jul-2006


Page: 1

Related medicine news :

1. Baby DVDs, videos may hinder, not help, infants language development
2. Millennium development goals: Are we on track?
3. New drug development facility helps move medicines to market
4. Mid Sweden University leads development of digital color x-rays
5. NIH study tracks brain development in some 500 children across US
6. A first glimpse at healthy brain and behavioral development
7. Role of TRPM8 in the development of prostate cancer
8. SLEEP 2007 to present more than 1,100 new findings and developments on sleep disorders
9. Hebrew University research shows developmental problems for siblings of autistic children
10. New forecasting tool could reduce drug development costs
11. Pittsburgh ear study finds that fluid in the ear does not impair development in children

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prebiotics can cut development skin allergy babies high risk

(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
(Date:9/2/2015)... , Sept. 2, 2015   About ELISA test ... common laboratory technologies that is used for measuring the ... solution. ELISA test uses various types of enzymes such ... the result is detected by photometry or fluorometry. ELISA ... of various infectious diseases such as HIV, pernicious anemia, ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP is ... trial will commence October 13, 2015. ... 510K fast-track approval program, Zimmer NexGen knee implant surpassed ... requires that companies provide evidence that the product is ... order to gain permissions. In 2001, ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
Cached News: